XGen Pharmaceuticals DJB
Rob Liles has extensive work experience in the pharmaceutical industry. Rob is currently working as the Chief Operating Officer (C.O.O.) at XGen Pharmaceuticals DJB since January 2020. Prior to this role, they held the position of Chief Operating Officer at X-Gen Pharmaceuticals Inc. from August 2016 to January 2020.
Rob Liles attended the University of the Ozarks from 1978 to 1982, where they obtained a Bachelor of Science degree in BA.
XGen Pharmaceuticals DJB
Approaching the end of a 20 year career at a major pharmaceutical company, Dan Badia made a discovery. Where larger companies found obsolescence in small markets or low-profit yielding drugs, Dan saw reliable solutions proven to be effective and affordable alternatives for healthcare. With his wife, Shirley Harmening, Dan founded a company in 1973 on a bridge table in his bedroom. In just 14 years, this company would outgrow its birthplace and find a home in lower upstate New York. That growth would be sustained by introducing injectables into an established product line, mainly consisting of anti-infective, compounding powders. In 2003, that company would become X-GEN Pharmaceuticals, Inc. Affirming Dan’s original vision while embracing a dynamic industry, family-owned X-GEN Pharmaceuticals, Inc. remained a leader in generic, anti-infective pharmaceuticals. In this our 50th year in affiliation, we honor this heritage by carrying our founder’s initials in our new name, XGen Pharmaceuticals DJB. With reverence for the past and a passion for the future, we expect big results, driven by bold solutions and delivered by real people.